Skip to main content
. 2020 Dec 8;4(1):101–106. doi: 10.1021/acsptsci.0c00170

Figure 4.

Figure 4

(a) Dose–response effects of the supramolecular complex on the viability of HepG2 spheroids treated with 600 μM FFA, n = 3 ± SD, *p < 0.05. Secretion of (b) TNF-α, (c) IL-6, and (d) IL-8 of healthy and FFA treated HepG2 spheroids to evaluate the anti-inflammatory effect of SMC, n = 3 ± SD, *p < 0.05.